title: Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir.
authors.affiliation: Fédération d'Hépatologie, Service d'Hépato-gastroentérologie, Limoges, France; Inserm UMR 1092, Faculté de Médecine de Limoges, Limoges, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Loustaud-Ratti
authors.forename: Paul
authors.initials: P
authors.lastname: Carrier
authors.forename: Chanlina
authors.initials: C
authors.lastname: Vong
authors.forename: Marie
authors.initials: M
authors.lastname: Essig
mesh_terms: D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects*; D011392:Proline / Q000031:analogs & derivatives*; D051437:Renal Insufficiency / Q000139:chemically induced*
chemical_list: D009842:Oligopeptides; D011392:Proline